Covered Call Analyzer from Investment Enhancing Systems, Inc.

The Covered Call Analyzer

$10,000 Monitored Aggressive Portfolio Trades fo October 17, 2009

This is a rolling portfolio and we will look at open positions and make new trades using monies from called and sold positions each month on expiration weekend. The statements starting "Buy...." is what the Covered Call Analyzer tells you to do after finding the best buy/writes and calculating the values.
Close Window

Call Premium Cost Balance

From September: $394

From Aggressive "Stocks-to-Consider" August 22, 2009 and putting $2,000 in the money available field

Buy 200 shares of MCMORAN EXPLORATION CO (MMR) at $8.28 (closing last trade price) and sell 2 call Out-of-the-Money contracts of MMR IB (Sep$10.00) at $0.25 (closing bid price) expiring on 9/19/2009. Cost is $1,666, and income from sale of the calls is $37 and includes your commissions. Annualized return if called is 290%. Not called on September 19. Will now sell Oct10 at $0.25. Price at $8.61 and value at $1,796, up 7.8% on September 19 including sale of all calls. Not called on October 17. Will now sell Nov10 at $0.25. Price at $8.16 and value at $1,743, up 4.6% on October 17 including sale of all calls.
$37 $431

Buy 100 shares of TAKE-TWO INTERA SOFTWARE (TTWO) at $10.29 (closing last trade price) and sell 1 call Out-of-the-Money contracts of TUO IV (Sep$12.50) at $0.30 (closing bid price) expiring on 9/19/2009. Cost is $1,039, and income from sale of the calls is $19 and includes your commissions. Annualized return if called is 289%. Not called on September 19. Will now sell Oct12.5 at $0.45. Price at $11.73 and value at $1,222, 17.6% on September 19 including sale of all calls. Not called on October 17. Will now sell Nov12.5 at $0.30. Price at $11.18 and value at $1,189, up 14.4% on October 17 including sale of all calls.
$17 $448

Buy 100 shares of AMYLIN PHARMACEUTICALS (AMLN) at $13.48 (closing last trade price) and sell 1 call Out-of-the-Money contracts of AQM IC (Sep$15.00) at $0.25 (closing bid price) expiring on 9/19/2009. Cost is $1,358, and income from sale of the calls is $14 and includes your commissions. Annualized return if called is 150%. Not called on September 19. Will now sell Oct15 at $0.30. Price at $13.10 and value at $1,342, down (1.2%) on September 19 including sale of all calls. Not called on October 17. Will now sell Nov15 at $0.55. Price at $13.89 and value at $1,464, up 7.9% on October 17 including sale of all calls.
$43 $491

From Aggressive "Stocks-to-Consider" September 19, 2009 and putting $2,000 in the money available field

Buy 100 shares of VANDA PHARMACEUTICALS (VNDA) at $12.59 (closing last trade price) and sell 1 call Out-of-the-Money contracts of QDX JC (Oct$15.00) at $1.15 (closing bid price) expiring on 10/17/2009. Cost is $1,269, and income from sale of the calls is $104 and includes your commissions. Annualized return if called is 320%. Exercised get-out price at $10.70 (-15%) on October 2 after buying back calls at $0.05. Proceeds $1,060 after commission. Final value including sale of all calls is $1,157, down (8.8%).
($17) $1,534

Buy 300 shares of ONCOTHYREON INC (ONTY) at $6.34 (closing last trade price) and sell 3 call Out-of-the-Money contracts of KKQ JU (Oct$7.50) at $0.40 (closing bid price) expiring on 10/17/2009. Cost is $1,912, and income from sale of the calls is $106 and includes your commissions. Annualized return if called is 284%. Exercised get-out price at $5.39 (-15%) on September 24 after buying back calls at $0.05. Proceeds $1,607 after commission. Final value including sale of all calls is $1,693, down (11.4%).
($30) $3,111

Buy 200 shares of SINOVAC BIOTECH LTD (SVA) at $8.88 (closing last trade price) and sell 2 call Out-of-the-Money contracts of SVA JB (Oct$10.00) at $0.75 (closing bid price) expiring on 10/17/2009. Cost is $1,786, and income from sale of the calls is $137 and includes your commissions. Annualized return if called is 239%. Exercised get-out price at $7.60 (-15%) on October 2 after buying back calls at $0.05. Proceeds $1,510 after commission. Final value including sale of all calls is $1,634, down (8.5%).
($23) $4,598

Buy 200 shares of PONIARD PHARMACEUTICALS (PARD) at $7.06 (closing last trade price) and sell 2 call Out-of-the-Money contracts of FQR JU (Oct$7.50) at $1.05 (closing bid price) expiring on 10/17/2009. Cost is $1,422, and income from sale of the calls is $197 and includes your commissions. Annualized return if called is 233%.Not called on October 17. Will now sell Nov7.5 at $2.20. Price at $6.87 and value at $1,998, up 40.5% on October 17 including sale of all calls.
$207 $4,805

Buy 200 shares of SPECTRUM PHARMACEUTICALS (SPPI) at $7.18 (closing last trade price) and sell 2 call Out-of-the-Money contracts of QBV JU (Oct$7.50) at $0.80 (closing bid price) expiring on 10/17/2009. Cost is $1,446, and income from sale of the calls is $147 and includes your commissions. Annualized return if called is 165%. Exercised get-out price at $6.10 (-15%) on October 9 after buying back calls at $0.05. Proceeds $1,210 after commission. Final value including sale of all calls is $1,344, down (7.0%).
($23) $5,992

Buy 200 shares of ZALE CORP (ZLC) at $7.16 (closing last trade price) and sell 2 call Out-of-the-Money contracts of ZLC JU (Oct$7.50) at $0.75 (closing bid price) expiring on 10/17/2009. Cost is $1,442, and income from sale of the calls is $137 and includes your commissions. Annualized return if called is 160%. Called on October 17 at $7.50. Proceeds $1,490 after commission. Total return including call premium is $1,627, up 12.8%.
$7,482

Buy 200 shares of JAZZ PHARMACEUTICALS INC (JAZZ) at $9.50 (closing last trade price) and sell 2 call Out-of-the-Money contracts of JWQ JB (Oct$10.00) at $0.80 (closing bid price) expiring on 10/17/2009. Cost is $1,910, and income from sale of the calls is $147 and includes your commissions. Annualized return if called is 149%. Exercised get-out price at $8.08 (-15%) on October 1 after buying back calls at $0.05. Proceeds $1,606 after commission. Final value including sale of all calls is $1,740, down (8.9%).
($23) $9,065

Buy 300 shares of MATRIXX INITIATIVES INC (MTXX) at $5.72 (closing last trade price) and sell 3 call Out-of-the-Money contracts of IHU JU (Oct$7.50) at $0.35 (closing bid price) expiring on 10/17/2009. Cost is $1,726, and income from sale of the calls is $91 and includes your commissions. Annualized return if called is 439%. Not called on October 17. Will now sell Nov7.5 at $0.25. Price at $5.56 and value at $1,819, up 5.4% on October 17 including sale of all calls.
$60 $9,125

Buy 200 shares of MGIC INVESTMENTS CORP (MTG) at $8.76 (closing last trade price) and sell 2 call Out-of-the-Money contracts of MTG JB (Oct$10.00) at $0.55 (closing bid price) expiring on 10/17/2009. Cost is $1,762, and income from sale of the calls is $97 and includes your commissions. Annualized return if called is 231%. Exercised get-out price at $7.45 (-15%) on September 30 after buying back calls at $0.05. Proceeds $1,480 after commission. Final value including sale of all calls is $1,564, down (11.2%).
($23) $10,582

From Aggressive "Stocks-to-Consider" October 17, 2009 and putting $2,000 in the money available field

Buy 200 shares of PONIARD PHARMACEUTICALS (PARD) at $6.87 (closing last trade price) and sell 2 call Out-of-the-Money contracts of FQR KU (Nov$7.50) at $2.20 (closing bid price) expiring on 11/21/2009. Cost is $1,394, and income from sale of the calls is $427 and includes your commissions. Annualized return if called is 388%.
$427 $1,394 $9,615

Buy 300 shares of MGIC INVESTMENTS CORP (MTG) at $6.42 (closing last trade price) and sell 3 call Out-of-the-Money contracts of MTG KU (Nov$7.50) at $0.35 (closing bid price) expiring on 11/21/2009. Cost is $1,946, and income from sale of the calls is $91 and includes your commissions. Annualized return if called is 206%.
$91 $1,946 $7,760

Buy 200 shares of RADIAN GROUP (RDN) at $7.10 (closing last trade price) and sell 2 call Out-of-the-Money contracts of RDN KU (Nov$7.50) at $1.00 (closing bid price) expiring on 11/21/2009. Cost is $1,440, and income from sale of the calls is $187 and includes your commissions. Annualized return if called is 174%.
$187 $1,440 $6,507

Buy 200 shares of BIOCRYST PHARMACEUTICALS (BCRX) at $9.41 (closing last trade price) and sell 2 call Out-of-the-Money contracts of BIU KB (Nov$10.00) at $0.85 (closing bid price) expiring on 11/21/2009. Cost is $1,902, and income from sale of the calls is $157 and includes your commissions. Annualized return if called is 136%.
$157 $1,902 $4,762

Buy 200 shares of LIZ CLAIBORNE INC (LIZ) at $7.05 (closing last trade price) and sell 2 call Out-of-the-Money contracts of LIZ KU (Nov$7.50) at $0.65 (closing bid price) expiring on 11/21/2009. Cost is $1,430, and income from sale of the calls is $117 and includes your commissions. Annualized return if called is 133%.
$117 $1,430 $3,449

Buy 200 shares of DEVELOPERS DIVERSIFIED (DDR) at $9.40 (closing last trade price) and sell 2 call Out-of-the-Money contracts of DDR KB (Nov$10.00) at $0.65 (closing bid price) expiring on 11/21/2009. Cost is $1,900, and income from sale of the calls is $117 and includes your commissions. Annualized return if called is 116%.
$117 $1,900 $1,666

Buy 100 shares of TENNECO INC (TEN) at $14.29 (closing last trade price) and sell 1 call Out-of-the-Money contracts of TEN KC (Nov$15.00) at $1.00 (closing bid price) expiring on 11/21/2009. Cost is $1,449, and income from sale of the calls is $89 and includes your commissions. Annualized return if called is 98%.
$89 $1,449 $306

Totals for October:
$1,410 $11,461 $306

Portfolio value at October 17 is $18,808*, up +88.1%. The NASDAQ average for the year so far is up +41.0%

*After the effect of all commissions.

The stocks listed above are for illustrative and educational purposes only and should not be construed as an endorsement, recommendation, or solicitation to buy or sell any particular security.

On January 17, 2009 (expiration weekend), Investment Enhancing Systems, Inc. initiated a new $10,000 aggressive portfolio for 2009, This portfolio uses stocks identified in our Aggressive "Stocks-to-Consider" list by selecting buy/writes from the "Stocks with high or negative PE ratios" list. We have set the money available to $2,000 and have reduced the commissions for purchasing the stock to $9.95 and selling the calls to $9.95 plus $1.50 per contract in our parameters page. Several low cost, on-line brokers offer these low commissions. Since it is an aggressive portfolio, we keep the premium income and stock price appreciation to the strike price in the portfolio. We update the portfolio each month on expiration weekend. Our objective is to maintain and grow the portfolio. The table above lists details of stocks bought and calls sold, and when we held the stock and sold more calls or exercised our get-out price. Note: In all of our lists and portfolios, we have established a get-out price which we exercise when the stock price drops 15%. If this happens during the month, we will get-out and report the sale of the stock and the buy-back of the calls at the next expiration weekend postings. We anticipate good months and poor months, with a general gain at year end. Patience usually wins.

	Call Premium	Cost	Balance
From September:			$394
From Aggressive "Stocks-to-Consider" August 22, 2009 and putting $2,000 in the money available field
Buy 200 shares of MCMORAN EXPLORATION CO (MMR) at $8.28 (closing last trade price) and sell 2 call Out-of-the-Money contracts of MMR IB (Sep$10.00) at $0.25 (closing bid price) expiring on 9/19/2009. Cost is $1,666, and income from sale of the calls is $37 and includes your commissions. Annualized return if called is 290%. Not called on September 19. Will now sell Oct10 at $0.25. Price at $8.61 and value at $1,796, up 7.8% on September 19 including sale of all calls. Not called on October 17. Will now sell Nov10 at $0.25. Price at $8.16 and value at $1,743, up 4.6% on October 17 including sale of all calls.	$37		$431
Buy 100 shares of TAKE-TWO INTERA SOFTWARE (TTWO) at $10.29 (closing last trade price) and sell 1 call Out-of-the-Money contracts of TUO IV (Sep$12.50) at $0.30 (closing bid price) expiring on 9/19/2009. Cost is $1,039, and income from sale of the calls is $19 and includes your commissions. Annualized return if called is 289%. Not called on September 19. Will now sell Oct12.5 at $0.45. Price at $11.73 and value at $1,222, 17.6% on September 19 including sale of all calls. Not called on October 17. Will now sell Nov12.5 at $0.30. Price at $11.18 and value at $1,189, up 14.4% on October 17 including sale of all calls.	$17		$448
Buy 100 shares of AMYLIN PHARMACEUTICALS (AMLN) at $13.48 (closing last trade price) and sell 1 call Out-of-the-Money contracts of AQM IC (Sep$15.00) at $0.25 (closing bid price) expiring on 9/19/2009. Cost is $1,358, and income from sale of the calls is $14 and includes your commissions. Annualized return if called is 150%. Not called on September 19. Will now sell Oct15 at $0.30. Price at $13.10 and value at $1,342, down (1.2%) on September 19 including sale of all calls. Not called on October 17. Will now sell Nov15 at $0.55. Price at $13.89 and value at $1,464, up 7.9% on October 17 including sale of all calls.	$43		$491
From Aggressive "Stocks-to-Consider" September 19, 2009 and putting $2,000 in the money available field
Buy 100 shares of VANDA PHARMACEUTICALS (VNDA) at $12.59 (closing last trade price) and sell 1 call Out-of-the-Money contracts of QDX JC (Oct$15.00) at $1.15 (closing bid price) expiring on 10/17/2009. Cost is $1,269, and income from sale of the calls is $104 and includes your commissions. Annualized return if called is 320%. Exercised get-out price at $10.70 (-15%) on October 2 after buying back calls at $0.05. Proceeds $1,060 after commission. Final value including sale of all calls is $1,157, down (8.8%).	($17)		$1,534
Buy 300 shares of ONCOTHYREON INC (ONTY) at $6.34 (closing last trade price) and sell 3 call Out-of-the-Money contracts of KKQ JU (Oct$7.50) at $0.40 (closing bid price) expiring on 10/17/2009. Cost is $1,912, and income from sale of the calls is $106 and includes your commissions. Annualized return if called is 284%. Exercised get-out price at $5.39 (-15%) on September 24 after buying back calls at $0.05. Proceeds $1,607 after commission. Final value including sale of all calls is $1,693, down (11.4%).	($30)		$3,111
Buy 200 shares of SINOVAC BIOTECH LTD (SVA) at $8.88 (closing last trade price) and sell 2 call Out-of-the-Money contracts of SVA JB (Oct$10.00) at $0.75 (closing bid price) expiring on 10/17/2009. Cost is $1,786, and income from sale of the calls is $137 and includes your commissions. Annualized return if called is 239%. Exercised get-out price at $7.60 (-15%) on October 2 after buying back calls at $0.05. Proceeds $1,510 after commission. Final value including sale of all calls is $1,634, down (8.5%).	($23)		$4,598
Buy 200 shares of PONIARD PHARMACEUTICALS (PARD) at $7.06 (closing last trade price) and sell 2 call Out-of-the-Money contracts of FQR JU (Oct$7.50) at $1.05 (closing bid price) expiring on 10/17/2009. Cost is $1,422, and income from sale of the calls is $197 and includes your commissions. Annualized return if called is 233%.Not called on October 17. Will now sell Nov7.5 at $2.20. Price at $6.87 and value at $1,998, up 40.5% on October 17 including sale of all calls.	$207		$4,805
Buy 200 shares of SPECTRUM PHARMACEUTICALS (SPPI) at $7.18 (closing last trade price) and sell 2 call Out-of-the-Money contracts of QBV JU (Oct$7.50) at $0.80 (closing bid price) expiring on 10/17/2009. Cost is $1,446, and income from sale of the calls is $147 and includes your commissions. Annualized return if called is 165%. Exercised get-out price at $6.10 (-15%) on October 9 after buying back calls at $0.05. Proceeds $1,210 after commission. Final value including sale of all calls is $1,344, down (7.0%).	($23)		$5,992
Buy 200 shares of ZALE CORP (ZLC) at $7.16 (closing last trade price) and sell 2 call Out-of-the-Money contracts of ZLC JU (Oct$7.50) at $0.75 (closing bid price) expiring on 10/17/2009. Cost is $1,442, and income from sale of the calls is $137 and includes your commissions. Annualized return if called is 160%. Called on October 17 at $7.50. Proceeds $1,490 after commission. Total return including call premium is $1,627, up 12.8%.			$7,482
Buy 200 shares of JAZZ PHARMACEUTICALS INC (JAZZ) at $9.50 (closing last trade price) and sell 2 call Out-of-the-Money contracts of JWQ JB (Oct$10.00) at $0.80 (closing bid price) expiring on 10/17/2009. Cost is $1,910, and income from sale of the calls is $147 and includes your commissions. Annualized return if called is 149%. Exercised get-out price at $8.08 (-15%) on October 1 after buying back calls at $0.05. Proceeds $1,606 after commission. Final value including sale of all calls is $1,740, down (8.9%).	($23)		$9,065
Buy 300 shares of MATRIXX INITIATIVES INC (MTXX) at $5.72 (closing last trade price) and sell 3 call Out-of-the-Money contracts of IHU JU (Oct$7.50) at $0.35 (closing bid price) expiring on 10/17/2009. Cost is $1,726, and income from sale of the calls is $91 and includes your commissions. Annualized return if called is 439%. Not called on October 17. Will now sell Nov7.5 at $0.25. Price at $5.56 and value at $1,819, up 5.4% on October 17 including sale of all calls.	$60		$9,125
Buy 200 shares of MGIC INVESTMENTS CORP (MTG) at $8.76 (closing last trade price) and sell 2 call Out-of-the-Money contracts of MTG JB (Oct$10.00) at $0.55 (closing bid price) expiring on 10/17/2009. Cost is $1,762, and income from sale of the calls is $97 and includes your commissions. Annualized return if called is 231%. Exercised get-out price at $7.45 (-15%) on September 30 after buying back calls at $0.05. Proceeds $1,480 after commission. Final value including sale of all calls is $1,564, down (11.2%).	($23)		$10,582
From Aggressive "Stocks-to-Consider" October 17, 2009 and putting $2,000 in the money available field
Buy 200 shares of PONIARD PHARMACEUTICALS (PARD) at $6.87 (closing last trade price) and sell 2 call Out-of-the-Money contracts of FQR KU (Nov$7.50) at $2.20 (closing bid price) expiring on 11/21/2009. Cost is $1,394, and income from sale of the calls is $427 and includes your commissions. Annualized return if called is 388%.	$427	$1,394	$9,615
Buy 300 shares of MGIC INVESTMENTS CORP (MTG) at $6.42 (closing last trade price) and sell 3 call Out-of-the-Money contracts of MTG KU (Nov$7.50) at $0.35 (closing bid price) expiring on 11/21/2009. Cost is $1,946, and income from sale of the calls is $91 and includes your commissions. Annualized return if called is 206%.	$91	$1,946	$7,760
Buy 200 shares of RADIAN GROUP (RDN) at $7.10 (closing last trade price) and sell 2 call Out-of-the-Money contracts of RDN KU (Nov$7.50) at $1.00 (closing bid price) expiring on 11/21/2009. Cost is $1,440, and income from sale of the calls is $187 and includes your commissions. Annualized return if called is 174%.	$187	$1,440	$6,507
Buy 200 shares of BIOCRYST PHARMACEUTICALS (BCRX) at $9.41 (closing last trade price) and sell 2 call Out-of-the-Money contracts of BIU KB (Nov$10.00) at $0.85 (closing bid price) expiring on 11/21/2009. Cost is $1,902, and income from sale of the calls is $157 and includes your commissions. Annualized return if called is 136%.	$157	$1,902	$4,762
Buy 200 shares of LIZ CLAIBORNE INC (LIZ) at $7.05 (closing last trade price) and sell 2 call Out-of-the-Money contracts of LIZ KU (Nov$7.50) at $0.65 (closing bid price) expiring on 11/21/2009. Cost is $1,430, and income from sale of the calls is $117 and includes your commissions. Annualized return if called is 133%.	$117	$1,430	$3,449
Buy 200 shares of DEVELOPERS DIVERSIFIED (DDR) at $9.40 (closing last trade price) and sell 2 call Out-of-the-Money contracts of DDR KB (Nov$10.00) at $0.65 (closing bid price) expiring on 11/21/2009. Cost is $1,900, and income from sale of the calls is $117 and includes your commissions. Annualized return if called is 116%.	$117	$1,900	$1,666
Buy 100 shares of TENNECO INC (TEN) at $14.29 (closing last trade price) and sell 1 call Out-of-the-Money contracts of TEN KC (Nov$15.00) at $1.00 (closing bid price) expiring on 11/21/2009. Cost is $1,449, and income from sale of the calls is $89 and includes your commissions. Annualized return if called is 98%.	$89	$1,449	$306
Totals for October:	$1,410	$11,461	$306
Portfolio value at October 17 is $18,808*, up +88.1%. The NASDAQ average for the year so far is up +41.0%